Mangalam Drugs and Organics – Double In a Month
Mangalam yesterday doubled from recommended price. Its was trading at around 17 PE and around 105cr market cap which is still 0.5 times its trailing Sales. PE though at 17 is trailing and therefore, slightly misleading as with the company is expected to come with good bottomline, the PE would get reduced. Those who have missed the bus can think of entering at some consolidation. Congratulations to the investors.
Ambika Cotton – Double in Six months
I did not expect that it would double so soon given low beta, but it came into lime light when it caught fancy of big and reputed investors. This is a steady compounder with good dividend yield. Congratulations to the investors.